扩大淋巴结清扫胰十二指肠切除手术治疗胰腺癌患者的效果

doi:10.3760/cma.j.cn441417-20241113-08020

摘要/Abstract

摘要：

目的　探讨扩大淋巴结清扫胰十二指肠切除手术（pancreatoduodenectomy，PD）治疗胰腺癌患者的效果。方法　选取2020年1月至2023年12月南阳市第二人民医院收治的78例胰腺癌患者进行随机对照试验。采用随机数字表法将其分为扩大清扫组与标准清扫组，各39例。扩大清扫组男22例，女17例，年龄（59.85±3.26）岁，体重指数（22.71±1.08）kg/m²，肿瘤长径（3.38±1.01）cm。标准清扫组男24例，女15例，年龄（60.05±3.34）岁，体重指数（22.78±1.12）kg/m²，肿瘤长径（3.40±0.97）cm。两组均行PD治疗，标准清扫组标准清扫淋巴结，扩大清扫组扩大清扫淋巴结。比较两组术中指标（手术时间、术中出血量、术中输血量、淋巴结清扫总数、阳性淋巴结清扫个数）、术后恢复指标（下床时间、首次流质饮食时间、引流管拔出时间、住院时间）、并发症发生率、淋巴结转移率、原位复发率及生存率。采用χ²检验与t检验进行统计分析。结果　扩大清扫组手术时间、术中出血量、术中输血量、淋巴结清扫总数、阳性淋巴结清扫个数分别为（401.36±38.90）min、（293.66±31.68）ml、（145.89±22.17）ml、（24.41±4.33）枚、（13.69±2.12）枚，标准清扫组分别为（376.52±33.22）min、（276.85±29.41）ml、（133.34±20.64）ml、（16.98±3.86）枚、（11.12±2.05）枚，差异均有统计学意义（均P<0.05）。两组下床时间、首次流质饮食时间、引流管拔出时间、住院时间、并发症总发生率、淋巴结转移率、原位复发率及生存率比较，差异均无统计学意义（均P>0.05）。结论　扩大淋巴结清扫PD治疗胰腺癌患者可提高淋巴结清扫总数及阳性淋巴结清扫个数，但扩大淋巴结清扫会增加手术创伤，延长手术时间，并不能提高患者生存率。

关键词:

胰腺癌, 扩大淋巴结清扫, 胰十二指肠切除手术, 围手术期指标, 并发症, 预后

Abstract:

Objective　To investigate the effect of extended lymph node dissection pancreaticoduodenectomy (PD) for patients with pancreatic adenocarcinoma. Methods　Seventy-eight patients with pancreatic adenocarcinoma treated in Nanyang Second People's Hospital from January 2020 to December 2023 were selected for the randomized controlled trial, and were divided into an extended dissection group and a standard dissection group by the random number table method, with 39 cases in each group. There were 22 males and 17 females in the expanded dissection group; they were (59.85±3.26) years old; their body mass index was (22.71±1.08) kg/m²; the maximum tumor diameter was (3.38±1.01) cm. There were 24 males and 15 females in the standard dissection group; they were (60.05±3.34) years old; their body mass index was (22.78±1.12) kg/m²; the maximum tumor diameter was (3.40±0.97) cm. Both groups were treated with PD; the standard dissection group took standard lymph node dissection, and the extended dissection group extended lymph node dissection. The intraoperative indicators (operation time, intraoperative bleeding volume, intraoperative blood transfusion volume, total number of lymph node dissection, and number of positive lymph node dissection), postoperative recovery indicators (time to get out of bed, time for first liquid diet, time to drainage tube extraction, and hospital stay), incidence rates of complications, lymph node metastasis rates, in situ recurrence rates, and survival rates were compared between the two groups. χ² and t tests were used for the statistical analysis. Results　The operation time, intraoperative bleeding volume, intraoperative blood transfusion volume, total number of lymph node dissection, and number of positive lymph node dissection in the extended dissection group were (401.36±38.90) min, (293.66±31.68) ml, (145.89±22.17) ml, 24.41±4.33, and 13.69±2.12; those in the standard dissection group were (376.52±33.22) min, (276.85±29.41) ml, (133.34±20.64) ml, 16.98±3.86, and 11.12±2.05; there were statistical differences (all P<0.05). There were no statistical differences in the time to get out of bed, time for first liquid diet, time to drainage tube extraction, hospital stay, total incidence rate of complications, lymph node metastasis rate, in situ recurrence rate, and survival rate between the two groups (all P>0.05). Conclusion　Extended lymph node dissection PD for patients with pancreatic adenocarcinoma can increase the total number of lymph node dissection and the number of positive lymph node dissection, but will increase the surgical trauma and prolong the surgical time, and can not improve the survival rate.

Key words:

Pancreatic adenocarcinoma, Extended lymph node dissection, Pancreaticoduodenectomy, Perioperative indicators, Complications, , Prognosis

李广洲王红雷贺洋胡翠陈艳浩.

扩大淋巴结清扫胰十二指肠切除手术治疗胰腺癌患者的效果 [J]. 国际医药卫生导报, 2025, 31(8): 1327-1331.

Li Guangzhou, Wang Honglei, He Yang, Hu Cui, Chen Yanhao.

Effect of extended lymph node dissection pancreaticoduodenectomy for patients with pancreatic adenocarcinoma [J]. International Medicine and Health Guidance News, 2025, 31(8): 1327-1331.

参考文献

[1] 李天宇,赵邦博,李泽儒,等.全胰切除术与胰十二指肠切除术治疗胰腺癌的手术疗效和生活质量对比分析:基于倾向性评分匹配的回顾性队列研究[J].协和医学杂志, 2024, 15(4): 807-818. DOI: 10.12290/xhyxzz.2024-0163.
[2] 陈浩达,汪超,苏秉蔚,等.机器人与开腹胰十二指肠切除术治疗胰腺癌的预后分析[J].中华消化外科杂志,2022,21(5):609-615. DOI: 10.3760/cma.j.cn115610- 20220430-00245.
[3] Datta J, Willobee BA, Ryon EL, et al. Contemporary reappraisal of intraoperative neck margin assessment during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a review [J]. JAMA Surg, 2021, 156(5): 489-495. DOI: 10.1001/jamasurg.2020.5676.
[4] 刘舜,谢诚,刘亚辉.胰腺导管腺癌行腹腔镜下胰十二指肠切除术后早期复发的列线图模型及其预测价值分析[J].临床肝胆病杂志,2024,40(1):138-146. DOI:10.12449/JCH240123.
[5] 刘泽群,孙文阁.基于MRI直方图模型预测胰腺癌淋巴结转移的初步研究[J].中国医学计算机成像杂志,2022,28(1):63-67. DOI:10.3969/j.issn.1006-5741.2022.01.013.
[6] 李倩,刘娜,鲁洁.巨噬细胞抑制因子-1、胰岛素样生长因子结合蛋白3、糖类抗原19-9检测对胰腺癌患者预后的预测价值[J].癌症进展,2023,21(19):2140-2143. DOI: 10.11877/j.issn.1672-1535.2023.21.19.13.
[7] 中国抗癌协会胰腺癌专业委员会.胰腺癌综合诊治指南(2018版)[J].中华外科杂志, 2018, 56(7): 481-494. DOI: 10.3760/cma.j.issn.0529-5815.2018.07.001.
[8] 傅冰洁,俞霞,李付贵,等.CA199联合血清异常凝血酶原在胰腺癌早期诊断中的临床价值[J].国际医药卫生导报,2020,26(7):973-976. DOI:10.3760/cma.j.issn. 1007-1245. 2020.07.025.
[9] Wang M,Pan S,Qin T,et al.Short-term outcomes following laparoscopic vs open pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma: a randomized clinical trial [J]. JAMA Surg, 2023, 158(12): 1245-1253. DOI: 10.1001/jamasurg.2023.5210.
[10] 刘成浩,王行雁,张利,等.局部进展期胰腺癌行胰十二指肠切除联合肝总动脉切除不重建1例[J].中华普通外科杂志,2024,39(3):224-225. DOI:10.3760/cma.j.cn113855- 20231108-00313.
[11] 胡浩,曲畅,田孝东,等.CPDC及SEER数据库中胰腺癌术后患者预后因素的比较研究[J].中华外科杂志,2021,59(9):770-776. DOI: 10.3760/cma.j.cn112139-20210507- 00202.
[12] 童小华,王菁菁.Galectin-9、Cadherin-11在胰腺癌组织中的表达及其与临床病理特征及预后的关系[J].检验医学与临床,2024,21(2):232-236. DOI: 10.3969/j.issn. 1672-9455. 2024.02.021.
[13] 吴鹏飞,张凯,田蕾,等.胰头癌胰十二指肠切除术中肠系膜上动脉左后侧淋巴结清扫的临床价值[J].中华外科杂志,2023,61(7):582-589. DOI:10.3760/cma.j.cn112139- 20230221-00077.
[14] 杨野梵,赵莎,龚予希,等.胰十二指肠切除术淋巴结清扫与胰头癌临床病理特征及预后的关系[J].中华普通外科杂志,2021,36(11):822-825. DOI:10.3760/cma.j.cn113855- 20210610-00356.
[15] 鄂毅峰.胰十二指肠切除手术在胰腺癌治疗中的应用效果[J].中国现代药物应用, 2020, 14(19): 67-69. DOI: 10.14164/j.cnki.cn11-5581/r.2020.19.027.
[16] 聂胜峰,杨锴,张敏,等.扩大淋巴结清扫术在胰腺十二指肠切除术中的价值[J].当代医学, 2021, 27(7): 38-41. DOI: 10.3969/j.issn.1009-4393.2021.07.015.
[17] 陈梅福,唐泽涛,姚佳水,等.8a组淋巴结在胰头癌根治术淋巴结清扫范围中的应用[J].中华肝胆外科杂志,2021,27(4):287-290. DOI: 10.3760/cma.j.cn113884-20200517- 00275.
[18] 邓海艳,李娟,张冰.双管双输法在急性上消化道出血患者血容量补充中的应用效果观察[J].临床急诊杂志,2020,21(1):87-91. DOI:10.13201/j.issn.1009-5918. 2020.01.015.
[19] 范红星,倪建勋,薄彪,等.术前白蛋白-胆红素评分以及其与CA19-9联合作为胰腺癌患者预后指标的临床价值[J].中国普通外科杂志,2020,29(3):310-316. DOI:10.7659/j.issn.1005-6947.2020.03.008.
[20] 薛佳豪,吴阳.扩大淋巴结清扫范围的胰十二指肠切除术治疗胰头癌的临床效果分析[J].肿瘤基础与临床, 2022, 35(2): 123-126. DOI:10.3969/j.issn.1673-5412. 2022.02.006.